Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 101,900 shares, a decrease of 21.2% from the October 15th total of 129,300 shares. Based on an average trading volume of 169,300 shares, the days-to-cover ratio is presently 0.6 days. Currently, 2.4% of the company’s shares are sold short.

Silo Pharma Price Performance

SILO stock traded down $0.02 during midday trading on Friday, reaching $1.13. The stock had a trading volume of 221,630 shares, compared to its average volume of 1,593,552. Silo Pharma has a twelve month low of $0.84 and a twelve month high of $4.50. The business has a fifty day simple moving average of $1.11 and a two-hundred day simple moving average of $1.39.

Silo Pharma (NASDAQ:SILO) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($0.31) earnings per share for the quarter. Silo Pharma had a negative return on equity of 63.95% and a negative net margin of 5,255.05%. The business had revenue of $0.02 million for the quarter.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.